|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
BRPI0922366B8
(pt)
*
|
2008-12-03 |
2021-05-25 |
Presidio Pharmaceuticals Inc |
composto, composição farmacêutica e uso de um composto
|
|
EP2367823A1
(en)
|
2008-12-23 |
2011-09-28 |
Abbott Laboratories |
Anti-viral compounds
|
|
ES2567047T3
(es)
|
2008-12-23 |
2016-04-19 |
Abbvie Inc. |
Derivados de pirimidina anti-virales
|
|
US8314135B2
(en)
|
2009-02-09 |
2012-11-20 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole antivirals
|
|
US8637561B2
(en)
*
|
2009-02-17 |
2014-01-28 |
Enanta Pharmaceuticals, Inc. |
Linked diimidazole derivatives
|
|
US8242156B2
(en)
|
2009-02-17 |
2012-08-14 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
US8394968B2
(en)
|
2009-02-17 |
2013-03-12 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8420686B2
(en)
|
2009-02-17 |
2013-04-16 |
Enanta Pharmaceuticals, Inc. |
Linked diimidazole antivirals
|
|
TWI438200B
(zh)
*
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
|
US8188132B2
(en)
|
2009-02-17 |
2012-05-29 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
MX2011008982A
(es)
*
|
2009-02-27 |
2011-09-15 |
Enata Pharmaceuticals Inc |
Inhibidores del virus de la hepatitis c.
|
|
US9765087B2
(en)
|
2009-02-27 |
2017-09-19 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
AU2013204195B2
(en)
*
|
2009-02-27 |
2016-09-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8673954B2
(en)
|
2009-02-27 |
2014-03-18 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
US8426458B2
(en)
*
|
2009-02-27 |
2013-04-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C Virus inhibitors
|
|
US8101643B2
(en)
|
2009-02-27 |
2012-01-24 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
US8507522B2
(en)
*
|
2009-03-06 |
2013-08-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
EP2410841A4
(en)
|
2009-03-27 |
2012-10-24 |
Presidio Pharmaceuticals Inc |
SUBSTITUTED BICYCLIC HCV INHIBITORS
|
|
TWI476190B
(zh)
*
|
2009-03-30 |
2015-03-11 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
|
US8796466B2
(en)
*
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
TW201038559A
(en)
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
JP5734956B2
(ja)
*
|
2009-04-15 |
2015-06-17 |
アッヴィ・インコーポレイテッド |
抗ウィルス化合物
|
|
JP2012526834A
(ja)
|
2009-05-12 |
2012-11-01 |
シェーリング コーポレイション |
ウイルス疾患治療に有用な縮合型三環式アリール化合物
|
|
MX363732B
(es)
*
|
2009-05-13 |
2019-04-01 |
Gilead Pharmasset Llc Star |
Compuestos antivirales.
|
|
US8211928B2
(en)
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8138215B2
(en)
|
2009-05-29 |
2012-03-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8980920B2
(en)
|
2009-05-29 |
2015-03-17 |
Merck Sharp & Dohme Corp. |
Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C
|
|
AU2010253790A1
(en)
*
|
2009-05-29 |
2011-12-15 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as Hepatitis C
|
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
|
US8716454B2
(en)
|
2009-06-11 |
2014-05-06 |
Abbvie Inc. |
Solid compositions
|
|
US9394279B2
(en)
|
2009-06-11 |
2016-07-19 |
Abbvie Inc. |
Anti-viral compounds
|
|
AR077060A1
(es)
|
2009-06-11 |
2011-07-27 |
Abbott Lab |
Compuestos antivirales
|
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8609648B2
(en)
|
2009-07-02 |
2013-12-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
JP2012533569A
(ja)
|
2009-07-16 |
2012-12-27 |
ヴァーテックス ファーマシューティカルズ、 インコーポレイテッド |
フラビウイルス感染症を治療又は予防するためのベンゾイミダゾール類似体
|
|
EA020816B1
(ru)
|
2009-07-21 |
2015-01-30 |
Джилид Сайэнс, Инк. |
Ингибиторы вирусов flaviviridae
|
|
WO2011015657A1
(en)
|
2009-08-07 |
2011-02-10 |
Tibotec Pharmaceuticals |
Phenyl ethynyl derivatives as hepatitis c virus inhibitors
|
|
WO2011015658A1
(en)
|
2009-08-07 |
2011-02-10 |
Tibotec Pharmaceuticals |
Bis-benzimidazole derivatives as hepatitis c virus inhibitors
|
|
EP2473503B1
(en)
|
2009-09-03 |
2014-07-23 |
Janssen R&D Ireland |
Bis-benzimidazole derivatives
|
|
EP2473056A4
(en)
|
2009-09-04 |
2013-02-13 |
Glaxosmithkline Llc |
CHEMICAL COMPOUNDS
|
|
JP5774008B2
(ja)
|
2009-09-09 |
2015-09-02 |
ギリアード サイエンシーズ, インコーポレイテッド |
Flaviviridaeウイルスの阻害剤
|
|
US8822700B2
(en)
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8703938B2
(en)
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8815928B2
(en)
|
2009-09-11 |
2014-08-26 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8927709B2
(en)
|
2009-09-11 |
2015-01-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8759332B2
(en)
|
2009-09-11 |
2014-06-24 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
EP2475256A4
(en)
|
2009-09-11 |
2013-06-05 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
WO2011031934A1
(en)
*
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
UA108211C2
(uk)
*
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
|
US20110269956A1
(en)
|
2009-11-11 |
2011-11-03 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110274648A1
(en)
|
2009-11-11 |
2011-11-10 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110281910A1
(en)
*
|
2009-11-12 |
2011-11-17 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
WO2011081918A1
(en)
|
2009-12-14 |
2011-07-07 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
|
US8377980B2
(en)
|
2009-12-16 |
2013-02-19 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
AR079528A1
(es)
|
2009-12-18 |
2012-02-01 |
Idenix Pharmaceuticals Inc |
Inhibidores de arileno o heteroarileno 5,5-fusionado del virus de la hepatitis c
|
|
WO2011075607A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
US20130156731A1
(en)
|
2009-12-22 |
2013-06-20 |
Kevin X. Chen |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas
|
|
CA2784036A1
(en)
*
|
2009-12-24 |
2011-06-30 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
US8362020B2
(en)
|
2009-12-30 |
2013-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
AU2011205744B2
(en)
|
2010-01-15 |
2015-06-25 |
Gilead Sciences, Inc. |
Inhibitors of Flaviviridae viruses
|
|
KR20120123678A
(ko)
|
2010-01-15 |
2012-11-09 |
길리애드 사이언시즈, 인코포레이티드 |
플라비비리다에 바이러스의 억제제
|
|
BR112012018529A2
(pt)
|
2010-01-25 |
2016-08-09 |
Enanta Pharm Inc |
inibidores do vírus de hepatite c, sua composição farmacêutica e seu uso, e método para inibição da replicação de um vírus contendo rna
|
|
US8933110B2
(en)
|
2010-01-25 |
2015-01-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8623814B2
(en)
|
2010-02-23 |
2014-01-07 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
US8178531B2
(en)
|
2010-02-23 |
2012-05-15 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
AU2010347272A1
(en)
*
|
2010-03-04 |
2012-09-20 |
Enanta Pharmaceuticals, Inc. |
Combination pharmaceutical agents as inhibitors of HCV replication
|
|
US8609635B2
(en)
|
2010-03-09 |
2013-12-17 |
Merck Sharp & Dohme Corp. |
Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
|
|
WO2011119860A1
(en)
*
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
CA2794145A1
(en)
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
EP2555622A4
(en)
|
2010-04-09 |
2013-09-18 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
KR20190061096A
(ko)
|
2010-04-22 |
2019-06-04 |
버텍스 파마슈티칼스 인코포레이티드 |
시클로알킬카르복스아미도-인돌 화합물의 제조 방법
|
|
WO2011150243A1
(en)
*
|
2010-05-28 |
2011-12-01 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
EP2575819A4
(en)
|
2010-06-04 |
2013-11-27 |
Enanta Pharm Inc |
INHIBITORS OF HEPATITIS C VIRUS
|
|
AR081848A1
(es)
*
|
2010-06-09 |
2012-10-24 |
Presidio Pharmaceuticals Inc |
Inhibidores de la proteina ns5a del vhc
|
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
|
EP2585448A1
(en)
|
2010-06-28 |
2013-05-01 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of flavivirus infections
|
|
MX2012014918A
(es)
|
2010-06-28 |
2013-04-08 |
Vertex Pharma |
Compuestos y metodos para tratamiento o prevencion de infecciones por flavivirus.
|
|
AU2011286276A1
(en)
|
2010-07-26 |
2013-01-24 |
Merck Sharp & Dohme Corp. |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
|
US8815849B2
(en)
|
2010-07-26 |
2014-08-26 |
Janssen R&D Ireland |
Hetero-bicyclic derivatives as HCV inhibitors
|
|
EA022127B1
(ru)
*
|
2010-08-04 |
2015-11-30 |
Бристол-Майерс Сквибб Компани |
Ингибиторы вируса гепатита с
|
|
US8697704B2
(en)
|
2010-08-12 |
2014-04-15 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
AU2011292040A1
(en)
|
2010-08-17 |
2013-03-07 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of Flaviviridae viral infections
|
|
EP2616461A4
(en)
*
|
2010-08-26 |
2014-03-26 |
Rfs Pharma Llc |
POTENTIVE AND SELECTIVE INHIBITORS OF HEPATITIS C VIRUS
|
|
US8822520B2
(en)
|
2010-09-22 |
2014-09-02 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic HCV inhibitors
|
|
CA2812699A1
(en)
*
|
2010-09-24 |
2012-03-29 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
|
WO2012050918A2
(en)
|
2010-09-29 |
2012-04-19 |
Presidio Pharmaceutical, Inc. |
Tricyclic fused ring inhibitors of hepatitis c
|
|
CN103459399A
(zh)
*
|
2010-09-29 |
2013-12-18 |
默沙东公司 |
用于治疗丙型肝炎病毒感染的四环吲哚衍生物
|
|
CA2812779A1
(en)
|
2010-09-29 |
2012-04-19 |
Merck Sharp & Dohme Corp. |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
|
JP2013538831A
(ja)
*
|
2010-09-29 |
2013-10-17 |
メルク・シャープ・エンド・ドーム・コーポレイション |
C型肝炎ウィルス感染治療のための四環式インドール誘導体
|
|
HUE026832T2
(en)
*
|
2010-10-13 |
2016-07-28 |
Abbvie Bahamas Ltd |
Antiviral 1-phenyl-2,5-dibenzimidazol-5-ylpyrrolidine derivative
|
|
AU2014203655B2
(en)
*
|
2010-10-13 |
2016-07-07 |
Abbvie Ireland Unlimited Company |
Anti-viral compounds
|
|
BR112013009789A2
(pt)
|
2010-10-26 |
2016-07-19 |
Presidio Pharmaceuticals Inc |
inibidores do vírus da hepatite c
|
|
CN103189371B
(zh)
|
2010-11-04 |
2015-04-01 |
施万生物制药研发Ip有限责任公司 |
丙型肝炎病毒抑制剂
|
|
JP5905020B2
(ja)
|
2010-11-17 |
2016-04-20 |
ギリアド ファーマセット エルエルシー |
抗ウイルス化合物
|
|
RU2452735C1
(ru)
*
|
2010-11-30 |
2012-06-10 |
Александр Васильевич Иващенко |
Замещенные азолы, противовирусный активный компонент, фармацевтическая композиция, способ получения и применения
|
|
US20150031884A1
(en)
*
|
2010-12-15 |
2015-01-29 |
Abbvie Inc. |
Anti-viral compounds
|
|
EP2651923A4
(en)
*
|
2010-12-15 |
2014-06-18 |
Abbvie Inc |
ANTI-VIRAL COMPOUNDS
|
|
WO2012083048A2
(en)
*
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP2651925A4
(en)
*
|
2010-12-15 |
2014-06-18 |
Abbvie Inc |
ANTI-VIRAL COMPOUNDS
|
|
EP2651885A1
(en)
*
|
2010-12-16 |
2013-10-23 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2012087976A2
(en)
*
|
2010-12-21 |
2012-06-28 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
WO2012091115A1
(ja)
*
|
2010-12-29 |
2012-07-05 |
キッセイ薬品工業株式会社 |
アセチレン誘導体及びその医薬用途
|
|
US8552047B2
(en)
|
2011-02-07 |
2013-10-08 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US9546160B2
(en)
|
2011-05-12 |
2017-01-17 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
|
CN103687489A
(zh)
|
2011-05-18 |
2014-03-26 |
埃南塔制药公司 |
制备5-氮杂螺[2.4]庚烷-6-甲酸及其衍生物的方法
|
|
AU2012280959B2
(en)
|
2011-07-13 |
2015-08-06 |
Gilead Sciences, Inc. |
Thiophen-2-carboxylic acid derivatives useful as inhibitors of Flaviviridae viruses
|
|
WO2013016501A1
(en)
|
2011-07-26 |
2013-01-31 |
Vertex Pharmaceuticals Incorporated |
Formulations of thiophene compounds
|
|
WO2013016499A1
(en)
|
2011-07-26 |
2013-01-31 |
Vertex Pharmaceuticals Incorporated |
Methods for preparation of thiophene compounds
|
|
WO2013030750A1
(en)
|
2011-09-01 |
2013-03-07 |
Lupin Limited |
Antiviral compounds
|
|
WO2013039876A1
(en)
|
2011-09-14 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
EP2709613B2
(en)
|
2011-09-16 |
2020-08-12 |
Gilead Pharmasset LLC |
Methods for treating hcv
|
|
PT3431477T
(pt)
|
2011-11-16 |
2020-12-15 |
Gilead Pharmasset Llc |
Imidazolilimidazolos condensados como compostos antivirais
|
|
ES2564906T3
(es)
*
|
2011-12-16 |
2016-03-29 |
F. Hoffmann-La Roche Ag |
Inhibidores de NS5A del VHC
|
|
CN104203940B
(zh)
*
|
2011-12-28 |
2017-01-18 |
爱尔兰詹森科学公司 |
作为hcv抑制剂的杂双环衍生物
|
|
EP2797913B1
(en)
|
2011-12-28 |
2016-08-17 |
Janssen Sciences Ireland UC |
Quinazolinone derivatives as hcv inhibitors
|
|
US9034832B2
(en)
|
2011-12-29 |
2015-05-19 |
Abbvie Inc. |
Solid compositions
|
|
US9326973B2
(en)
|
2012-01-13 |
2016-05-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
AU2013217224B2
(en)
|
2012-02-10 |
2017-04-06 |
Lupin Limited |
Antiviral compounds with a dibenzooxaheterocycle moiety
|
|
NZ630805A
(en)
|
2012-03-22 |
2016-01-29 |
Alios Biopharma Inc |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
AU2013250378B2
(en)
|
2012-04-17 |
2016-01-14 |
Fujifilm Corporation |
Nitrogen-containing heterocyclic compound or salt thereof
|
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
TWI610916B
(zh)
|
2012-08-03 |
2018-01-11 |
廣東東陽光藥業有限公司 |
作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用
|
|
US8841340B2
(en)
|
2012-08-17 |
2014-09-23 |
Gilead Sciences, Inc. |
Solid forms of an antiviral compound
|
|
US8927741B2
(en)
|
2012-08-17 |
2015-01-06 |
Gilead Sciences, Inc. |
Synthesis of an antiviral compound
|
|
US8759544B2
(en)
|
2012-08-17 |
2014-06-24 |
Gilead Sciences, Inc. |
Synthesis of an antiviral compound
|
|
US9802949B2
(en)
|
2012-11-29 |
2017-10-31 |
Sunshine Lake Pharma Co., Ltd. |
Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
|
|
US9416139B2
(en)
|
2012-11-29 |
2016-08-16 |
Sunshine Lake Pharma Co., Ltd. |
Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof
|
|
CN103880823B
(zh)
*
|
2012-12-21 |
2017-12-05 |
广东东阳光药业有限公司 |
作为丙型肝炎抑制剂的螺环化合物及其在药物中的应用
|
|
PL2950786T3
(pl)
|
2013-01-31 |
2020-05-18 |
Gilead Pharmasset Llc |
Formulacja skojarzona dwóch związków przeciwwirusowych
|
|
RU2507201C1
(ru)
|
2013-02-07 |
2014-02-20 |
Александр Васильевич Иващенко |
Алкил [(s)-1-((s)-2-{5-[4-(4-{2-[(s)-1-((s)-2-метоксикарбониламино-3-метил-бутирил)-пирролидин-2-ил]-3н-имидазол-4-ил}-бута-1,3-диинил)-фенил]-1н-имидазол-2-ил}-пирролидин-1-карбонил)-2-метил-пропил]-карбамат нафталин-1,5-дисульфонат, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний
|
|
US20150065439A1
(en)
|
2013-02-28 |
2015-03-05 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
|
US11484534B2
(en)
|
2013-03-14 |
2022-11-01 |
Abbvie Inc. |
Methods for treating HCV
|
|
US20150023913A1
(en)
|
2013-07-02 |
2015-01-22 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US9717712B2
(en)
|
2013-07-02 |
2017-08-01 |
Bristol-Myers Squibb Company |
Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
|
|
WO2015009744A1
(en)
|
2013-07-17 |
2015-01-22 |
Bristol-Myers Squibb Company |
Combinations comprising biphenyl derivatives for use in the treatment of hcv
|
|
PL3038601T3
(pl)
|
2013-08-27 |
2020-08-24 |
Gilead Pharmasset Llc |
Formulacja złożona dwóch związków przeciwwirusowych
|
|
EP3063140A4
(en)
|
2013-10-30 |
2017-11-08 |
Merck Sharp & Dohme Corp. |
Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
|
|
CN103664581B
(zh)
*
|
2013-12-20 |
2016-07-06 |
中节能万润股份有限公司 |
一种反,反-4,4’-二环己基二甲酸的制备方法
|
|
WO2015089810A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
EP3089757A1
(en)
|
2014-01-03 |
2016-11-09 |
AbbVie Inc. |
Solid antiviral dosage forms
|
|
WO2015110048A1
(en)
|
2014-01-23 |
2015-07-30 |
Sunshine Lake Pharma Co., Ltd. |
Bridged ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
|
|
PL3925607T3
(pl)
|
2014-04-15 |
2023-10-30 |
Vertex Pharmaceuticals Incorporated |
Kompozycje farmaceutyczne do leczenia chorób, w których pośredniczy mukowiscydozowy przezbłonowy regulator przewodnictwa
|
|
CN105175408B
(zh)
*
|
2014-06-04 |
2018-07-17 |
中国人民解放军第二军医大学 |
苯并噻唑类化合物及其作为药物的用途
|
|
TWI721947B
(zh)
|
2014-06-11 |
2021-03-21 |
美商基利法瑪席特有限責任公司 |
抗病毒化合物的固態形式
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
WO2017023631A1
(en)
|
2015-08-06 |
2017-02-09 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
|
CN106279117A
(zh)
*
|
2016-08-16 |
2017-01-04 |
上海同昌生物医药科技有限公司 |
一种雷迪帕韦中间体的合成方法及其产品
|
|
CN108727345B
(zh)
*
|
2017-04-25 |
2023-06-27 |
广东东阳光药业有限公司 |
一种咪唑环中间体的制备方法
|
|
KR102835299B1
(ko)
|
2018-12-04 |
2025-07-18 |
브리스톨-마이어스 스큅 컴퍼니 |
다중 동위원소체 반응 모니터링에 의한 샘플내 보정 곡선을 사용한 분석 방법
|
|
US12441707B2
(en)
|
2019-12-30 |
2025-10-14 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
US11760764B2
(en)
|
2020-05-22 |
2023-09-19 |
Aligos Therapeutics, Inc. |
Methods and compositions for targeting PD-L1
|
|
CR20230325A
(es)
|
2020-12-30 |
2023-12-11 |
Tyra Biosciences Inc |
Compuestos de indazol como inhibidores de cinasas
|
|
CN117460734A
(zh)
|
2021-05-21 |
2024-01-26 |
吉利德科学公司 |
作为寨卡病毒抑制剂的五环衍生物
|
|
WO2022246072A1
(en)
|
2021-05-21 |
2022-11-24 |
Gilead Sciences, Inc. |
Tetracyclic compounds for the treatment of zika virus infection
|
|
KR20240035395A
(ko)
|
2021-06-14 |
2024-03-15 |
스코르피온 테라퓨틱스, 인코퍼레이티드 |
암 치료에 사용할 수 있는 요소 유도체
|